Magyar K - Search Results

1

Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.

Gulyás B, Pavlova E, Kása P, Gulya K, Bakota L, Várszegi S, Keller E, Horváth MC, Nag S, Hermecz I, Magyar K, Halldin C. Gulyás B, et al. Among authors: magyar k. Neurochem Int. 2011 Jan;58(1):60-8. doi: 10.1016/j.neuint.2010.10.013. Epub 2010 Nov 12. Neurochem Int. 2011. PMID: 21075154

2

R-deprenyl: pharmacological spectrum of its activity.

Magyar K, Szende B, Jenei V, Tábi T, Pálfi M, Szöko E. Magyar K, et al. Neurochem Res. 2010 Dec;35(12):1922-32. doi: 10.1007/s11064-010-0238-8. Epub 2010 Aug 20. Neurochem Res. 2010. PMID: 20725780

3

(-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.

Magyar K, Szende B. Magyar K, et al. Neurotoxicology. 2004 Jan;25(1-2):233-42. doi: 10.1016/S0161-813X(03)00102-5. Neurotoxicology. 2004. PMID: 14697898 Review.

4

Pharmacological aspects of (-)-deprenyl.

Magyar K, Pálfi M, Tábi T, Kalász H, Szende B, Szöko E. Magyar K, et al. Curr Med Chem. 2004 Aug;11(15):2017-31. doi: 10.2174/0929867043364793. Curr Med Chem. 2004. PMID: 15279565 Review.

5

Behaviour of (-)-deprenyl and its analogues.

Magyar K. Magyar K. J Neural Transm Suppl. 1994;41:167-75. doi: 10.1007/978-3-7091-9324-2_23. J Neural Transm Suppl. 1994. PMID: 7931223 Review.

6

Altered nitric oxide production in mouse brain after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridin or methamphetamine.

Halász AS, Pálfi M, Tábi T, Magyar K, Szöko E. Halász AS, et al. Among authors: magyar k. Neurochem Int. 2004 Jun;44(8):641-6. doi: 10.1016/j.neuint.2003.09.003. Neurochem Int. 2004. PMID: 15016479

7

Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats.

Somfai GM, Knippel B, Ruzicska E, Stadler K, Tóth M, Salacz G, Magyar K, Somogyi A. Somfai GM, et al. Among authors: magyar k. Neurochem Int. 2006 Jun;48(8):746-52. doi: 10.1016/j.neuint.2005.12.009. Epub 2006 Mar 9. Neurochem Int. 2006. PMID: 16524643

8

Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease.

Szökő É, Tábi T, Riederer P, Vécsei L, Magyar K. Szökő É, et al. Among authors: magyar k. J Neural Transm (Vienna). 2018 Nov;125(11):1735-1749. doi: 10.1007/s00702-018-1853-9. Epub 2018 Feb 7. J Neural Transm (Vienna). 2018. PMID: 29417334 Review.

9

Antiapoptotic effect of (-)-deprenyl in rat kidney after ischemia-reperfusion.

Toronyi E, Hamar J, Magyar K, Szende B. Toronyi E, et al. Among authors: magyar k. Med Sci Monit. 2002 Feb;8(2):BR65-8. Med Sci Monit. 2002. PMID: 11859269

10

Pharmacokinetic aspects of deprenyl effects.

Magyar K, Tóthfalusi L. Magyar K, et al. Pol J Pharmacol Pharm. 1984 Jul-Aug;36(4):373-84. Pol J Pharmacol Pharm. 1984. PMID: 6441926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters